Overview

Ivermectin Nasal Drops in Post COVID Parosmia

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

The current study will be a pilot study for a randomized controlled trial conducted on patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine To evaluate the effect of ivermectin nasal drops in the treatment of post COVID 19 parosmia

Phase:

Phase 2

Details

Lead Sponsor:

Menoufia University

Treatments:

Budesonide
Ivermectin